Having spent his career helping companies navigate transformation, Alex Gedeon sees industrial AI as healthcare's next operational frontier. He explains how PartsSource evolved from a parts marketplace into an AI-powered medical fleet management company, and why the future of hospital operations will remain human-led yet inherently AI-enabled.

Blending his experience as a physician and AI researcher, Muthu Alagappan founded Counsel Health on the belief that healthcare should work like the rest of modern life: mobile, immediate, and on demand. Counsel's AI-powered, messaging-based platform augments physician capacity, expands patient access, and reimagines care delivery for a digital-first world.

Leading Google Cloud’s evolution into a healthcare intelligence layer, Aashima Gupta discusses how agentic AI is transforming access and personalization across care touchpoints. She references partnerships like CVS Health alongside Google’s efforts to operationalize Gemini and DeepMind innovations into scalable tools for providers, payers, and innovators.

Reimagining the future of payers, Andrew explores what it means to be truly AI-native at Clover Health: connecting fragmented data for earlier intervention, creating an API-to-truth, and sidestepping bot-on-bot warfare. From positioning the doctor as the primary UI to balancing patient privacy with innovation, he brings a technologist’s perspective to the top of healthcare’s capital stack.

Leveraging a career focused on the biology of aging, Jacob Kimmel explains how NewLimit uses advanced AI to navigate vast genetic combinations and prioritize experiments that reprogram cells to more youthful, functional states. With a large-scale data library, a small team, and a novel approach, NewLimit is developing therapies to enable longer, healthier lives.

Working at the intersection of chemistry, machine learning, and AI, Jacob and Eli Berlin discuss how Terray is transforming drug discovery. By building and testing small molecules at a massive scale, Terray accelerates candidate discovery in uncharted chemical space and redefines what an AI-native biotech can achieve.

Beginning his career in Salesforce optimization, Jassi has always worked at the intersection of technology and commercial operations. Today, Axtria helps pharma companies reach the right patients faster by leveraging AI to aggregate and synthesize vast datasets, unlocking patterns that identify unmet patient needs.

With a background in human genomics and a career devoted to patient safety, Aman leads ArisGlobal, an enterprise software company supporting safe, compliant, and efficient drug development. Driven by a collaborative, global, and tech-forward mindset, ArisGlobal unifies drug data to uncover patterns and enable smarter, faster decisions.

From coder to C-suite, Greg understands the pace of technological change, prioritizes highest value over lowest cost, and stays close to innovation. At BMS, he’s advancing both in-house AI applications and AI-powered R&D—unlocking hidden data patterns that can turn serendipity into systematic discovery.

We speak with biopharma leaders about how AI is decoding vast datasets across the discovery, development, and delivery phases to enable more effective therapies faster, safer, and at lower cost.